Create your own destiny
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What are u talking about
If there is any value they will just transfer everything good to cytocom, and sht on shareholders as they always done , still holding those worthless spinoff shares as well
What about cytocom complete bs of a spin off ???
News by Friday buy!!
No go through the filings it's all there
New patent awarded
Watt the future !!!
Watt!! Pnm! Dis! Hot this week
Hope they fkin burn had my sell order in at 13 at the bid. Never filled had plenty of time literally 10 minutes , crooks stay away from this shit
There Loading up, patience buddy you saw the report its a joke at these prices with the amount of shares outstanding this will move up easily
$win $unis $ms $ Pnm bullish
Unis deal with Amgen done going up much hogher
UNIS supernova today deal with Amgen done
On December 17, 2015, the conditions necessary for purchases under the Purchase Agreement to commence were satisfied. On any trading day on which the closing sale price of our common stock exceeds $0.10, we have the right, in our sole discretion, to present Aspire Capital with a purchase notice (each, a “Purchase Notice”), directing Aspire Capital (as principal) to purchase up to 150,000 shares of our common stock per trading day, provided that the aggregate price of such purchase shall not exceed $500,000 per trading day, up to $25.0 million of our Common Stock in the aggregate at a per share price (the “Purchase Price”) calculated by reference to the prevailing market price of our common stock (as more specifically described below).
5
In addition, on any date on which we submit a Purchase Notice for 150,000 shares to Aspire Capital and the closing sale price of our stock is equal to or greater than $0.50 per share of Common Stock, we also have the right, in our sole discretion, to present Aspire Capital with a volume-weighted average price purchase notice (each, a “VWAP Purchase Notice”) directing Aspire Capital to purchase an amount of stock equal to up to 30% of the aggregate shares of our Common Stock traded on the NASDAQ on the next trading day (the “VWAP Purchase Date”), subject to a maximum number of shares we may determine (the “VWAP Purchase Share Volume Maximum”) and a minimum trading price (the “VWAP Minimum Price Threshold”) (as more specifically described below). The purchase price per share pursuant to such VWAP Purchase Notice (the “VWAP Purchase Price”) is calculated by reference to the prevailing market price of our Common Stock (as more specifically described below).
The Purchase Agreement provides that the Company and Aspire Capital shall not affect any sales under the Purchase Agreement on any purchase date where the closing sale price of our Common Stock is less than $0.10 per share (the “Floor Price”). This Floor Price and the respective prices and share numbers in the preceding paragraphs shall be appropriately adjusted for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction. There are no trading volume requirements or restrictions under the Purchase Agreement, and we will control the timing and amount of any sales of our common stock to Aspire Capital. Aspire Capital has no right to require any sales by us, but is obligated to make purchases from us as we direct in accordance with the Purchase Agreement. There are no limitations on use of proceeds, financial or business covenants, restrictions on future fundings, rights of first refusal, participation rights, penalties or liquidated damages in the Purchase Agreement. Aspire Capital may not assign its rights or obligations under the Purchase Agreement. The Purchase Agreement may be terminated by us at any time, at our discretion, without any penalty or cost to us.
The issuance of the all shares to Aspire Capital under the Purchase Agreement is exempt from registration under the Securities Act, pursuant to the exemption for transactions by an issuer not involving any public offering under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D promulgated thereunder.
Bottom tested .48 bounced .55 pivot for reversal
UNIS BReakout today!!
UNIS $$$ close deal with Amgen anyday deadline Friday 11:59 !!!
UNIS $$$ close deal with Amgen anyday deadline Friday 11:59 !!!
What u trying to say
You will see it soon today is also last day for shorts to cover before getting flagged threshold
Yeah with super low volume, deal is done, earnings coming out , payment of 1.7 mil moved to feb 9th , just shaking the weak today
20 mil short interest ! Unis Amgen deal anyday
20 mil short interest to be covered in 5 days!!!!
They will reverse split period, they are already approved for it could come anyday
Picked up 500$ worth Loto play
Pursuant to and subject to the terms of the Fourth Amendment to the Credit Agreement, the Lender agreed to defer the due date for the December 31, 2015 interest payment (in the amount of $1,700,857.37) to February 5, 2016. Additionally, the Borrower agreed to pay interest on such deferred amount from December 31, 2015 at the rate set forth in the Amended Credit Agreement and to pay all fees and expenses incurred by the Lender in connection with the Fourth Amendment to the Credit Agreement.
Basically saying there gonna pay the last remaining debt in cash feb 6th I would call that good news 1.6 mil$
Funds coming in tmrro il take a retrace to .71-75 anyday unis= no brainer